A prognostic risk model for HCC was established using 11 circadian clock-related long noncoding RNAs (lncRNAs) and the risk score analysis showed a significant association with tumor immunity that can guide more effective prognostic and therapeutic strategies [165]. The gene discussed is CLOCK; the disease is hepatocellular carcinoma.